collection
MENU ▼
Read by QxMD icon Read
search

acretismo

shared collection
3 papers 0 to 25 followers
https://www.readbyqxmd.com/read/26393335/severe-placental-abruption-clinical-definition-and-associations-with-maternal-complications
#1
Cande V Ananth, Jessica A Lavery, Anthony M Vintzileos, Daniel W Skupski, Michael Varner, George Saade, Joseph Biggio, Michelle A Williams, Ronald J Wapner, Jason D Wright
BACKGROUND: Placental abruption traditionally is defined as the premature separation of the implanted placenta before the delivery of the fetus. The existing clinical criteria of severity rely exclusively on fetal (fetal distress or fetal death) and maternal complications without consideration of neonatal or preterm delivery-related complications. However, two-thirds of abruption cases are accompanied by fetal or neonatal complications, including preterm delivery. A clinically meaningful classification for abruption therefore should include not only maternal complications but also adverse fetal and neonatal outcomes that include intrauterine growth restriction and preterm delivery...
February 2016: American Journal of Obstetrics and Gynecology
https://www.readbyqxmd.com/read/21316642/accreta-complicating-complete-placenta-previa-is-characterized-by-reduced-systemic-levels-of-vascular-endothelial-growth-factor-and-by-epithelial-to-mesenchymal-transition-of-the-invasive-trophoblast
#2
Mark J Wehrum, Irina A Buhimschi, Carolyn Salafia, Stephen Thung, Mert O Bahtiyar, Erica F Werner, Katherine H Campbell, Christine Laky, Anna K Sfakianaki, Guomao Zhao, Edmund F Funai, Catalin S Buhimschi
OBJECTIVE: We sought to characterize serum angiogenic factor profile of women with complete placenta previa and determine if invasive trophoblast differentiation characteristic of accreta, increta, or percreta shares features of epithelial-to-mesenchymal transition. STUDY DESIGN: We analyzed gestational age-matched serum samples from 90 pregnant women with either complete placenta previa (n = 45) or uncomplicated pregnancies (n = 45). Vascular endothelial growth factor (VEGF), placental growth factor, and soluble form of fms-like-tyrosine-kinase-1 were immunoassayed...
May 2011: American Journal of Obstetrics and Gynecology
https://www.readbyqxmd.com/read/24373590/surgical-management-of-placenta-accreta-to-leave-or-remove-the-placenta
#3
REVIEW
A Perez-Delboy, J D Wright
Abnromalities of placentation, including placenta accreta, represent a major source of morbidity and mortality among women. Traditional management consists of peripartum hysterectomy at the time of delivery, although more conservative treatments have also been developed recently. In this review we describe the available literature describing the operative approach and considerations for management of women with placenta accreta.
January 2014: BJOG: An International Journal of Obstetrics and Gynaecology
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"